“Concerns about a recession and runaway inflation make it even more critical that employers are able to hire and keep top talent, and getting unreasonable health care costs under control can have a far-reaching impact on wages and ability to compete.”

The company has reaped nearly $100 billion from selling covid-19 vaccines and treatments to U.S. taxpayers and foreign governments. With that windfall, it plans to get richer, sinking the cash into developing and marketing potential blockbusters for conditions like migraines, ulcerative colitis, prostate cancer, sickle cell disease, and obesity.

The open enrollment season for health insurance is gearing up at a time when more people in the United States have health insurance than ever before. Yet millions of Americans who enroll this fall still won’t be able to easily afford the health care they need or will be hit with medical bills they can’t pay. Why? ...

Sen. Mark Warner (D-Va.), chairman of the Senate Intelligence Committee, released a report on Thursday outlining cybersecurity threats in the health care sector and ways the federal government can improve security standards in the industry. The report, which is divided into three sections, recommends that the federal government improve the country’s cybersecurity risk posture in the health care sector, help the private ...

In the current Congress, Democrats were able to expand Affordable Care Act (ACA) subsidies and introduce drug price reforms, but experts say there could still be some progress on areas of common ground if Republicans take one or both chambers of Congress.

Government negotiation of Medicare drug prices—even for a small set of older, single-source drugs—is a remarkable policy development. But how exactly will the government do it? The Inflation Reduction Act (IRA), signed into law August 16, contains an 86-page blueprint laying out which drugs are on the table, implementation timelines, “factors” to be considered, and rules of engagement ...